Adma Biologics Stock Performance
| ADMA Stock | USD 15.94 1.58 9.02% |
ADMA Biologics has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ADMA Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding ADMA Biologics is expected to be smaller as well. ADMA Biologics at this time shows a risk of 2.88%. Please confirm ADMA Biologics treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to decide if ADMA Biologics will be following its price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ADMA Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady primary indicators, ADMA Biologics may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return (5.88) | Five Day Return (2.77) | Year To Date Return (7.77) | Ten Year Return 197.65 | All Time Return 92.87 |
1 | Brokers Suggest Investing in Adma Biologics Read This Before Placing a Bet | 12/01/2025 |
2 | Why Adma Biologics Outpaced the Stock Market Today | 01/06/2026 |
3 | ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update | 01/12/2026 |
4 | How ADMAs MultiYear Revenue Targets And Margin Push At ADMA Biologics Has Changed Its Investment Story | 01/13/2026 |
5 | Assessing ADMA Biologics After Recent Pullback And Strong DCF Upside Potential | 01/15/2026 |
6 | ADMA Biologics Is Down 5.0 percent After Expanding Multi-Year Revenue Guidance Targets - Has The Bull Case Changed | 01/22/2026 |
7 | Kornitzer Capital Management Inc. KS Acquires 312,115 Shares of ADMA Biologics Inc ADMA | 01/28/2026 |
8 | Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN | 01/30/2026 |
| Begin Period Cash Flow | 51.4 M | |
| Total Cashflows From Investing Activities | -8.6 M |
ADMA Biologics Relative Risk vs. Return Landscape
If you would invest 1,452 in ADMA Biologics on November 7, 2025 and sell it today you would earn a total of 142.00 from holding ADMA Biologics or generate 9.78% return on investment over 90 days. ADMA Biologics is currently generating 0.1939% in daily expected returns and assumes 2.8819% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than ADMA, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ADMA Biologics Target Price Odds to finish over Current Price
The tendency of ADMA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 15.94 | 90 days | 15.94 | about 85.4 |
Based on a normal probability distribution, the odds of ADMA Biologics to move above the current price in 90 days from now is about 85.4 (This ADMA Biologics probability density function shows the probability of ADMA Stock to fall within a particular range of prices over 90 days) .
ADMA Biologics Price Density |
| Price |
Predictive Modules for ADMA Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ADMA Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ADMA Biologics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ADMA Biologics is not an exception. The market had few large corrections towards the ADMA Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ADMA Biologics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ADMA Biologics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.18 | |
β | Beta against Dow Jones | 0.72 | |
σ | Overall volatility | 1.68 | |
Ir | Information ratio | 0.05 |
ADMA Biologics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ADMA Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ADMA Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN |
ADMA Biologics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ADMA Stock often depends not only on the future outlook of the current and potential ADMA Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ADMA Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 243.3 M | |
| Cash And Short Term Investments | 103.1 M |
ADMA Biologics Fundamentals Growth
ADMA Stock prices reflect investors' perceptions of the future prospects and financial health of ADMA Biologics, and ADMA Biologics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ADMA Stock performance.
| Return On Equity | 0.63 | ||||
| Return On Asset | 0.22 | ||||
| Profit Margin | 0.43 % | ||||
| Operating Margin | 0.38 % | ||||
| Current Valuation | 4.19 B | ||||
| Shares Outstanding | 238 M | ||||
| Price To Earning | (1.55) X | ||||
| Price To Book | 9.67 X | ||||
| Price To Sales | 8.05 X | ||||
| Revenue | 426.45 M | ||||
| Gross Profit | 267.28 M | ||||
| EBITDA | 147.69 M | ||||
| Net Income | 197.67 M | ||||
| Cash And Equivalents | 52.42 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 82.12 M | ||||
| Debt To Equity | 1.32 % | ||||
| Current Ratio | 7.94 X | ||||
| Book Value Per Share | 1.81 X | ||||
| Cash Flow From Operations | 118.67 M | ||||
| Earnings Per Share | 0.81 X | ||||
| Market Capitalization | 3.94 B | ||||
| Total Asset | 488.68 M | ||||
| Retained Earnings | (308.58 M) | ||||
| Working Capital | 275.87 M | ||||
| Current Asset | 21.29 M | ||||
| Current Liabilities | 4.22 M | ||||
About ADMA Biologics Performance
By analyzing ADMA Biologics' fundamental ratios, stakeholders can gain valuable insights into ADMA Biologics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ADMA Biologics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ADMA Biologics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 270.28 | 294.05 | |
| Return On Tangible Assets | 0.37 | 0.39 | |
| Return On Capital Employed | 0.37 | 0.35 | |
| Return On Assets | 0.36 | 0.38 | |
| Return On Equity | 0.65 | 0.62 |
Things to note about ADMA Biologics performance evaluation
Checking the ongoing alerts about ADMA Biologics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ADMA Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN |
- Analyzing ADMA Biologics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ADMA Biologics' stock is overvalued or undervalued compared to its peers.
- Examining ADMA Biologics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ADMA Biologics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ADMA Biologics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ADMA Biologics' stock. These opinions can provide insight into ADMA Biologics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |